Quantcast
Last updated on April 23, 2014 at 15:23 EDT

Latest Anesthetic Stories

2009-02-24 04:00:00

Like general anesthesia without the risks   CORONA DEL MAR, Calif., Feb. 24 /PRNewswire/ -- General anesthesia (GA) remains a popular anesthetic for cosmetic surgery. More enlightened surgeons and anesthesia providers avoid GA for cosmetic surgery. Unfortunately, the attitudes of their national organizations still lag behind these safety-first visionaries.   The public should not confuse 'safer than before' GA with 'safest achievable' anesthesia.   Were 'safest achievable'...

2009-01-16 16:51:21

The U.S. Food and Drug Administration is warning of potentially life-threatening side effects of skin numbing products. The products, known as topical anesthetics contain lidocaine, tetracaine, benzocaine and prilocaine in a cream, ointment or gel. The FDA is concerned the anesthetic drugs, if used improperly, may cause life-threatening side effects, such as irregular heartbeat, seizures, breathing difficulties, coma or even death. The agency said two women died using topical anesthetics...

2009-01-13 19:11:08

Previous studies have overestimated the risks of severe complications of epidurals and spinal anesthetics, British researchers said. The study, published in the British Journal of Anesthesia, concluded that the estimated risk of permanent harm following a spinal anesthetic or epidural is lower than 1 in 20,000 and in many circumstances the estimated risk is considerably lower. The study found that the odds of being badly injured by an epidural or spinal anesthetic are considerably better...

2009-01-12 15:31:18

The largest ever prospective study into the major complications of epidurals and spinal anesthetics published in the British Journal of Anesthesia today (Monday 12 January 2009) concludes that previous studies have over-estimated the risks of severe complications of these procedures. The study concludes that the estimated risk of permanent harm following a spinal anesthetic or epidural is lower than 1 in 20,000 and in many circumstances the estimated risk is considerably lower. The study...

2008-12-14 10:00:00

PARSIPPANY, N.J., Dec. 14 /PRNewswire/ -- A Phase II trial of a single intraoperative administration of EXPAREL (DepoBupivacaine) resulted in significantly reduced pain with activity in the first 8 to 24 hours following surgery, when pain is generally greatest, compared to conventional treatment. The results of the multicenter, randomized, double-blind study were presented in a poster at the Annual Postgraduate Assembly in Anesthesiology in New York City today, by lead investigator...

2008-11-25 17:36:47

A commonly used anesthetic can produce changes associated with Alzheimer's disease in the brains of living mammals, U.S. researchers said. Massachusetts General Hospital investigators in Boston show how administration of the gas isoflurane can lead to generation of the toxic amyloid-beta protein -- associated with Alzheimer's disease -- in the brains of mice. These are the first results indicating that isoflurane can set off a time-dependent cascade inducing cell death and enhanced levels of...

2008-11-05 18:00:22

U.S. and German researchers using a new animal model of genetic mutations say they've discovered some common anesthetics trigger arrhythmias in humans. Researchers from Brown University, Rhode Island Hospital, Pennsylvania State University and the University of Freiburg, Germany, said they developed a novel animal model to study what happens in humans with genetic mutations leading to arrhythmias and-or sudden cardiac death. The mutations cause Long QT Syndrome, a disorder of the heart's...

2008-10-28 09:00:39

KENILWORTH, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Schering-Plough Corp., today announced that a study published in the November 2008 issue of the medical journal, Anesthesiology (Vol. 109, No. 5)(1) demonstrated that sugammadex produced a significantly more rapid recovery from profound rocuronium-induced muscle relaxation than the conventional reversal agent neostigmine. Importantly, this is the first comparative study to demonstrate that rapid reversal of profound rocuronium-induced...

2008-10-16 12:00:25

Akorn, a provider of sterile specialty pharmaceuticals, has commercially launched Akten gel 3.5%, a topical ocular anesthetic ophthalmic drug product. According to the company, Akten represents the first FDA approved drug product indicated for use as an ocular anesthetic in four decades. Akten is the only approved ocular gel formulation that also contains the highest concentration of lidocaine. Akten can also be used as a local anesthetic indicated for ocular surface anesthesia during...

2008-10-15 09:00:48

Akorn, Inc. (NASDAQ: AKRX) today announced the commercial launch of Akten(TM) Gel 3.5%, a topical ocular anesthetic ophthalmic drug product. Akten(TM) represents the first FDA approved drug product indicated for use as an ocular anesthetic in four decades. Akten(TM) is the only approved ocular gel formulation that also contains the highest concentration of lidocaine. Akten(TM) has several unique features: it is preservative free, non toxic to the cornea, does not sting due to its...